Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1984 1
1986 1
1987 1
1989 1
1990 2
1993 1
1994 1
1995 4
1996 1
1997 1
1998 12
1999 3
2000 3
2001 8
2002 9
2003 5
2004 11
2005 13
2006 12
2007 11
2008 10
2009 9
2010 7
2011 9
2012 8
2013 7
2014 9
2015 4
2016 9
2017 7
2018 6
2019 9
2020 12
2021 12
2022 8
2023 7
2024 19
2025 10
2026 10

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

250 results

Results by year

Filters applied: . Clear all
Page 1
A review of the pathophysiology, etiology, and treatment of attention-deficit hyperactivity disorder (ADHD).
Sharma A, Couture J. Sharma A, et al. Ann Pharmacother. 2014 Feb;48(2):209-25. doi: 10.1177/1060028013510699. Epub 2013 Nov 1. Ann Pharmacother. 2014. PMID: 24259638 Review.
OBJECTIVE: To review the pathophysiology, etiology, and treatment of attention-deficit hyperactivity disorder (ADHD). DATA SOURCES AND DATA EXTRACTION: A literature search was conducted in PubMed and EMBASE using the terms attention de …
OBJECTIVE: To review the pathophysiology, etiology, and treatment of attention-deficit hyperactivity disorder ( …
Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis.
Cortese S, Adamo N, Del Giovane C, Mohr-Jensen C, Hayes AJ, Carucci S, Atkinson LZ, Tessari L, Banaschewski T, Coghill D, Hollis C, Simonoff E, Zuddas A, Barbui C, Purgato M, Steinhausen HC, Shokraneh F, Xia J, Cipriani A. Cortese S, et al. Lancet Psychiatry. 2018 Sep;5(9):727-738. doi: 10.1016/S2215-0366(18)30269-4. Epub 2018 Aug 7. Lancet Psychiatry. 2018. PMID: 30097390 Free PMC article.
BACKGROUND: The benefits and safety of medications for attention-deficit hyperactivity disorder (ADHD) remain controversial, and guidelines are inconsistent on which medications are preferred across different age groups. We aimed to estimate the …
BACKGROUND: The benefits and safety of medications for attention-deficit hyperactivity disorder (ADHD) re …
Bupropion.
Huecker MR, Smiley A, Saadabadi A. Huecker MR, et al. 2024 Sep 2. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan–. 2024 Sep 2. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan–. PMID: 29262173 Free Books & Documents.
Since its approval in 1985, bupropion has been utilized off-label for various conditions, including antidepressant-induced sexual dysfunction, depression associated with bipolar disorder, obesity, and ADHD in pediatric patients. This activity reviews bupro …
Since its approval in 1985, bupropion has been utilized off-label for various conditions, including antidepressant-induced sexual dys …
Attention-Deficit/Hyperactivity Disorder in Adults.
Olagunju AE, Ghoddusi F. Olagunju AE, et al. Am Fam Physician. 2024 Aug;110(2):157-166. Am Fam Physician. 2024. PMID: 39172673
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder involving functionally disruptive inattentive and/or hyperactive/impulsive behaviors, such as being easily distracted, regularly failing to follow through on …
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder involving functio …
Bupropion for attention deficit hyperactivity disorder (ADHD) in adults.
Verbeeck W, Bekkering GE, Van den Noortgate W, Kramers C. Verbeeck W, et al. Cochrane Database Syst Rev. 2017 Oct 2;10(10):CD009504. doi: 10.1002/14651858.CD009504.pub2. Cochrane Database Syst Rev. 2017. PMID: 28965364 Free PMC article.
BACKGROUND: Attention deficit hyperactivity disorder (ADHD) is a prevalent neurobiological condition, characterised by behavioral and cognitive symptoms such as inattention, impulsivity and/or excessive activity. ...AUTHORS' CONCLUSIONS: The fin …
BACKGROUND: Attention deficit hyperactivity disorder (ADHD) is a prevalent neurobiological condition, cha …
Pharmacologic treatment of attention deficit hyperactivity disorder in adults: A systematic review and network meta-analysis.
Elliott J, Johnston A, Husereau D, Kelly SE, Eagles C, Charach A, Hsieh SC, Bai Z, Hossain A, Skidmore B, Tsakonas E, Chojecki D, Mamdani M, Wells GA. Elliott J, et al. PLoS One. 2020 Oct 21;15(10):e0240584. doi: 10.1371/journal.pone.0240584. eCollection 2020. PLoS One. 2020. PMID: 33085721 Free PMC article.
BACKGROUND: Attention deficit hyperactivity disorder (ADHD) affects approximately 3% of adults globally. ...There was no significant difference in the risk of serious adverse events or treatment discontinuation between ADHD pharmacotherap …
BACKGROUND: Attention deficit hyperactivity disorder (ADHD) affects approximately 3% of adults globally. …
Alternative pharmacological strategies for adult ADHD treatment: a systematic review.
Buoli M, Serati M, Cahn W. Buoli M, et al. Expert Rev Neurother. 2016;16(2):131-44. doi: 10.1586/14737175.2016.1135735. Epub 2016 Jan 14. Expert Rev Neurother. 2016. PMID: 26693882
Adult Attention Deficit Hyperactivity Disorder (ADHD) is a prevalent psychiatric condition associated with high disability and frequent comorbidity. ...Antidepressants, particularly those acting as noradrenaline or dopamine enhancers, have evide …
Adult Attention Deficit Hyperactivity Disorder (ADHD) is a prevalent psychiatric condition associated wit …
Bupropion Mediated Effects on Depression, Attention Deficit Hyperactivity Disorder, and Smoking Cessation.
Clark A, Tate B, Urban B, Schroeder R, Gennuso S, Ahmadzadeh S, McGregor D, Girma B, Shekoohi S, Kaye AD. Clark A, et al. Health Psychol Res. 2023 Jul 1;11:81043. doi: 10.52965/001c.81043. eCollection 2023. Health Psychol Res. 2023. PMID: 37405312 Free PMC article.
The drug has been used to treat depression, Attention Deficit Hyperactivity Disorder (ADHD), and smoking cessation. This investigation reviews the pharmacokinetic and pharmacodynamic effects of bupropion and its mechanisms of action and i …
The drug has been used to treat depression, Attention Deficit Hyperactivity Disorder (ADHD), and smoking …
Bupropion.
Wilkes S. Wilkes S. Drugs Today (Barc). 2006 Oct;42(10):671-81. doi: 10.1358/dot.2006.42.10.1025701. Drugs Today (Barc). 2006. PMID: 17136226 Review.
Bupropion was initially developed and licensed for the treatment of major depressive disorder in the United States in 1989. ...In addition to proven clinical efficacy for the treatment of major depression, the prevention of depressive episodes in patients with seaso …
Bupropion was initially developed and licensed for the treatment of major depressive disorder in the United States in 1989. .. …
Pharmacological Treatment of Binge Eating Disorder and Frequent Comorbid Diseases.
Himmerich H, Bentley J, McElroy SL. Himmerich H, et al. CNS Drugs. 2024 Sep;38(9):697-718. doi: 10.1007/s40263-024-01111-1. Epub 2024 Aug 3. CNS Drugs. 2024. PMID: 39096466 Review.
Binge eating disorder (BED) is the most common specific eating disorder (ED). It is frequently associated with attention deficit hyperactivity disorder (ADHD), depression, bipolar disorder (BD), anxiety disorders, alc …
Binge eating disorder (BED) is the most common specific eating disorder (ED). It is frequently associated with atten …
250 results